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MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF TWO 
VERY VIRULENT INFECTIOUS BURSAL DISEASE VIRUS ISOLATES, 
UPM94/273 AND UPM97/61 
By 
KONG L1H LING 
February 2003 
Chairman :  Associate Professor Dr. Abdul Rahman Omar, Ph.D. 
Faculty: Veterinary Medicine 
An atypical very virulent (w) strain (UPM94/273) and typical vv strain 
(UPM97/61) of infectious bursal disease virus (IBOV) isolated in 
Malaysia, were characterized both in vivo and at the molecular level. 
Comparison of the deduced amino acid sequences with other serotype 1 
and 2 sequences revealed 16 amino acid residues, which were 
conserved only in the vvIBDV. Among the 16 unique amino acid 
differences, 8 were in VP1 (146 Asp, 147 Asn, 242 Glu, 390 Met, 393 
Asp, 562 Pro, 687 Pro and 695 Arg), 3 were in VP2 (222 Ala, 256 lie and 
294 lie), 2 were in VP3 (990 Val and 1005 Ala) and 3 were in VP4 (685 
Asn, 715 Ser and 751 Asp). The importance of these unique amino acid 
residues is not known but they could affect the virulence of vvIBOV. The 
UPM94/273 also demonstrated 6 unique amino acid residues at segment 
111 
A at positions Ser254, Glu270, Lys588, Ser745, Phe838 and Lys863 and 
8 unique amino acid residues at segment B at positions Ala92, Ser1 00, 
Va1208, Asp253, Asp560, Asn565, Gly750 and Gly876. In addition, these 
amino acid substitutions have not been reported before in wlBDV and 
were found only on variant, classical and/or serotype 2 strains. However, 
the VP5 region of both wlBDV strains was conserved. The 
UPM97/61 demonstrated 7 unique amino acid substitutions at segment A 
and 4 unique amino acid substitutions at segment B .  However, none of 
the amino acids changes have been reported elsewhere in other IBDV 
strains. Although the actual functions of the amino acid substitutions are 
not know, the unusual amino acid substitutions at segment A and/or B of 
both isolates may be important in virus viru lence. Alignments of the 
nucleic acid and amino acid sequences of segment A and B followed by 
distance analysis al lowed the generation of phylogenetic trees. 
Phylogenetic analysis based on segment A and B revealed that all the 
wlBDV strains including UPM94/273 isolate can be clustered in a group 
that is d istinct from classical ,  variant, attenuated and serotype 2 strains. 
However, the tree branching patterns were qu ite different between 
segment A and segment B. in addition , the wlBDV strains showed 
several conserved amino acid substitutions at segment B as found in the 
Australian 002-73 and serotype 2 strains. These findings indicate that 
probably a genetic reassortment may have play an important role in the 
emergence of vvIBDV. Flow cytometry and real time peR assays, 
indicated that chickens infected with UPM97/61 induced higher 
IV 
percentages of apoptotic cells but lower level of viral load whereas 
UPM94/273 induced lower percentages of apoptotic cel ls but higher level 
of viral load, suggesting a negative correlation between viral load and 
apoptosis. These results indicated that UPM97/61 was more virulent than 
UPM94/273. 
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Virus penyakit bursa berjangkit amat virulen (wi OBV) yang tidak khusus 
(UPM94/273) dan yang khusus (UPM97/61 ) d iperolehi dari Malaysia, 
telah d icirikan dalam vivo dan berdasarkan molekul .  Perbandingan 
jujukan asid amino dengan jujukan serotip 1 dan 2 yang lain telah 
menunjukkan 1 6  asid amino residu yang cuma terdapat d i  wIBOV. 
Perbezaan antara 1 6  asid amino yang unik ini ,  8 terdapat di VP1 ( 146 
Asp, 1 47 Asn,  242 Glu, 390 Met, 393 Asp, 562 Pro, 687 Pro dan 695 
Arg), 3 terdapat di VP2 (222 Ala, 256 lie dan 294 l ie), 2 terdapat di VP3 
(990 Val dan 1 005 Ala) dan 3 terdapat di VP4 (685 Asn, 71 5 Ser dan 751 
Asp). Kepentingan residu-residu asid amino ini adalah tidak diketahui 
tetapi ia boleh mempengaruhi viru len vvIBOV. UPM94/273 juga 
menunjukkan 6 asid amino yang unik pad a kedudukan Ser254, Glu270, 
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Lys588, Ser745, Phe838 dan Lys863 mana setiap 2 berada d i  VP2, VP3 
dan VP4. Tambahan pula, penggantian asid amino pad a kedudukan 
Gly254Ser, Ala270Glu, Glu588Lys dan Asp745Ser cuma terdapat di 
varian ,  klasik dan/atau serotip 2. Walaubagaimanapun, bahagian VP5 
untuk kedua-dua wlBOV adalah kekal. UPM97/61 menunjukkan 7 
penggantian asid amino yang unik d i  segmen A dan 4 penggantian asid 
amino yang unik d i  segmen B.  Tetapi, perubahan asid amino in i  tidak 
pernah dilaporkan pada strain-strain IBOV yang lain. Walaupun fungsi 
sebenar penggantian asid amino adalah tidak diketahui, tetapi 
penggantian asid amino yang luar biasa ini pada segmen A dan/atau B 
untuk kedua-dua isolat mungkin penting dalam virulen virus. Susunan 
untuk jujukan asid nukleik dan asid amino untuk segmen A dan B diikuti 
oleh anal isis jarak membenarkan pembentukan pokok filogenetik. 
Analisis filogenetik berdasarkan segmen A dan B menunjukkan semua 
strain wlBOV termasuk isolat UPM94/273 IBOV boleh d ikumpulkan 
dalam satu kumpulan d i  mana adalah berbeza daripada strain-strain 
klasik, varian, akenuat dan serotip 2. Walaupun begitu , corak-corak untuk 
cabangan pokok adalah berlainan antara segmen A dan segmen B. 
Tambahan pula, strain-strain wlBOV menunjukkan beberapa 
penggantian asid amino yang kekal dalam segmen B seperti yang 
dijumpai dalam strain-strain Australian 002-73 dan serotip 2. Penemuan 
ini menyatakan bahawa kemungkinan penyusunan semula genetic yang 
mungkin memainkan peranan yang penting dalam kemunculan wIBOV. 
Cara-cara aliran sitometri dan PCR masa sebenar, menyatakan bahawa 
VB 
ayam-ayam yang dijangkiti dengan UPM97/61 mengakibatkan peratusan 
sel-sel apoptosis yang lebih tinggi tetapi takat muatan virus yang lebih 
rendah manakala UPM94/273 mengakibatkan peratusan sel-sel 
apoptosis yang lebih rendah tetapi takat muatan virus yang lebih tinggi, 
mencadangkan satu perhubungan yang negatif wujud d i  antara muatan 
virus dan apoptosis. Keputusan ini menyatakan bahawa UPM97/61 
adalah lebih virulen daripada UPM94/273. 
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I nfectious bursal disease (IBD) is an acute contagious viral 
disease of young chickens (Kibenge et al. , 1 988; Lasher et al. , 1 994). 
The etiological agent, IBD virus ( IBDV), has a predilection for the cells of 
the bursa of Fabricius where the virus infects actively d ividing and 
differentiating lymphocytes of the B-cell l ineage (Burkhardt et al. , 1 987). 
Thus, IBD is a fatal immunosuppressive disease causing heavy losses to 
the poultry industry (Eterradossi et al., 1 998). 
The first outbreak of IBD was reported in commercial chicken 
flocks in Delaware, USA (Cosgrove, 1 962). The IBDV strains, which were 
isolated during this outbreak, are now referred to as classical serotype I 
isolates. Later on, a second serotype - serotype" of IBDV was identified 
(McNulty and Saif, 1 988). These isolates are apathogenic and are 
recovered mainly from turkeys ( Ismail et al. , 1 988). Based on antigenic 
variation and virulence, serotype I isolates can be divided into several 
groups : classical virulent, attenuated, antigenic variant and very viru lent 
(w) strains (Cao et al. , 1 998). Since 1 985, antigenic variants of serotype 
I I BDV isolates had been recovered from flocks with selection pressure of 
field vaccination against classical IBDV serotype I (Snyder, 1 990). 
Although being antigenic variant, these isolates have only minor amino 
acid changes and do not form any separate serotype. Nevertheless, 
these changes occur at the VP2 conformation-dependent antigenic 
epitopes that are responsible for stimulating virus neutral izing antibodies 
(Bayl iss et al., 1 990). In 1 991 , IBOV isolates, which were able to break 
through levels of maternal antibodies that were normally protective,  were 
reported in Europe (Chettle et al. , 1 989). These isolates, the so cal led 
very virulent IBOV (wIBOV), cause more severe clinical signs during an 
outbreak with "mortality approaching 1 00% in susceptible flocks, and are 
now found almost world-wide (VandenBerg, 2000). 
The emergence of highly virulent strains of IBOV has complicated 
the immunization programs against the disease. Early vaccination may 
result in fai lure due to interference with the maternal antibody, whilst its 
delay may cause field virus infections. Therefore, it is important to 
characterize the antigenicity and the virulence of IBOV in both vaccine 
and field strains in the control of the disease. The effectiveness in the 
latter is also dependent on the diagnostic methods used. The d isease 
can be d iagnosed based on virus isolation, electron microscopy, 
immunofluorescence, virus neutralization, monoclonal antibody assays, 
and/or enzyme-linked immunosorbent assay (Lukert and Saif, 1 991 ; Wu 
et al. , 1 992; Liu et al., 1 994). However, these methods have one or more 
d isadvantages such as being time consuming, labour intensive, 
expensive and of low sensitivity (Wu et al. , 1 992). 
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Recently, more sensitive and specific molecular methods have 
been used to diagnose and characterize IBOV infections (Jackwood and 
Nielsen, 1 997; Moody et a/. , 2000; Boot et al. , 200 1 ). The reverse 
transcriptase polymerase chain (RT-PCR) has been widely used to 
detect IBOV (Tham et al., 1 995; Jackwood and Nielsen, 1 997). RT-PCR 
followed by restriction fragment length polymorphism (RFLP) has also 
been used to detect and d ifferentiate IBOV strains (Jackwood and 
Sommer, 1 997; Hoque et al., 200 1 ). RT-PCR RFLP profiles of the 
amplified hypervariable region of the VP2 gene have been used to 
d iagnose and identify molecular differences in the IBOV strains isolated 
in different parts of the world (Jackwood and Sommer, 1 999; Hoque et 
al., 2001 ). I n  these studies, it was found that al l wlBOV isolates have a 
conserved Ssp1 and Taq1 sites at the hypervariable region of the VP2 
gene. A study has also been carried out to develop a PCR method for the 
detection of IBOV based on colorimetric technique (Phong, 2002). 
Generally the severity of IBOV infections has been assessed in 
terms of mortal ity or the degree of bursal damage, and it has been 
difficult to assess viral load because viru lent strains of IBOV do not 
repl icate in tissue culture (Moody et al. , 2000). A quantitative competitive 
PCR (QC-PCR) assay has been developed to monitor IBOV RNA 
extracted from infected bursae (Wu et al. , 1 997). However, this protocol 
is labour intensive and the technique has limitations (Souaze et al. , 
1 996). Difficulties in using the RT -PCR technique for quantification 
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